Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer

• Hauptverfasser: Guillaume Sicard (Verfasst von), Clément Paris (Verfasst von), Sarah Giacometti (Verfasst von), Anne Rodallec (Verfasst von), Joseph Ciccolini (Verfasst von), Palma Rocchi (Verfasst von), Raphaëlle Fanciullino (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2020-11-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Prostate cancer (PCa) is the second most common cancer in men worldwide and the fifth leading cause of death by cancer. The overexpression of TCTP protein plays an important role in castration resistance. Over the last decade, antisense technology has emerged as a rising strategy in oncology. Using...